240 related articles for article (PubMed ID: 6275335)
1. Lung surfactant in an era of replacement therapy.
Notter RH; Shapiro DL
Pediatrics; 1981 Dec; 68(6):781-9. PubMed ID: 6275335
[TBL] [Abstract][Full Text] [Related]
2. Biophysical behavior of lung surfactant: implications for respiratory physiology and pathophysiology.
Notter RH
Semin Perinatol; 1988 Jul; 12(3):180-212. PubMed ID: 3041603
[TBL] [Abstract][Full Text] [Related]
3. Lung surfactants for replacement therapy: biochemical, biophysical, and clinical aspects.
Notter RH; Shapiro DL
Clin Perinatol; 1987 Sep; 14(3):433-79. PubMed ID: 3311535
[TBL] [Abstract][Full Text] [Related]
4. The effect of exogenous surfactant replacement therapy on lung function.
Yüksel B; Greenough A
Turk J Pediatr; 1993; 35(1):53-7. PubMed ID: 8236518
[TBL] [Abstract][Full Text] [Related]
5. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
Robertson B
Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
[TBL] [Abstract][Full Text] [Related]
6. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology.
Jobe A
Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946
[TBL] [Abstract][Full Text] [Related]
7. Surfactant replacement in neonatal and adult respiratory distress syndrome.
Robertson B
Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
[TBL] [Abstract][Full Text] [Related]
8. The era of pulmonary surfactant from Laplace to nowadays.
Parmigiani S; Solari E
Acta Biomed; 2003 Aug; 74(2):69-75. PubMed ID: 14509914
[TBL] [Abstract][Full Text] [Related]
9. Exogenous surfactant therapy in newborns.
Rodriguez RJ; Martin RJ
Respir Care Clin N Am; 1999 Dec; 5(4):595-616. PubMed ID: 10565883
[TBL] [Abstract][Full Text] [Related]
10. [Surfactant treatment of acute pulmonary failure. Other indications than neonatal distress syndrome].
Silberg IE; Grønn M
Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1456-8. PubMed ID: 9198922
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary surfactant: functions, abnormalities and therapeutic options.
Frerking I; Günther A; Seeger W; Pison U
Intensive Care Med; 2001 Nov; 27(11):1699-717. PubMed ID: 11810113
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary surfactant.
Dobbs LG
Annu Rev Med; 1989; 40():431-46. PubMed ID: 2658759
[TBL] [Abstract][Full Text] [Related]
13. Lung development and the pulmonary surfactant system: hormonal ifluences.
Hitchcock KR
Anat Rec; 1980 Sep; 198(1):13-34. PubMed ID: 6257147
[TBL] [Abstract][Full Text] [Related]
14. Inherited disorders of neonatal lung diseases.
Yurdakök M
Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
[TBL] [Abstract][Full Text] [Related]
15. The biochemistry of fetal lung development.
Kresch MJ; Gross I
Clin Perinatol; 1987 Sep; 14(3):481-507. PubMed ID: 3311536
[TBL] [Abstract][Full Text] [Related]
16. Controversies regarding surfactant replacement therapy.
Shapiro DL; Notter RH
Clin Perinatol; 1988 Dec; 15(4):891-902. PubMed ID: 3061705
[TBL] [Abstract][Full Text] [Related]
17. Exogenous surfactant therapy: newer developments.
Lacaze-Masmonteil T
Semin Neonatol; 2003 Dec; 8(6):433-40. PubMed ID: 15001115
[TBL] [Abstract][Full Text] [Related]
18. Characterization of bovine surfactant for infants with respiratory distress syndrome.
Taeusch HW; Keough KM; Williams M; Slavin R; Steele E; Lee AS; Phelps D; Kariel N; Floros J; Avery ME
Pediatrics; 1986 Apr; 77(4):572-81. PubMed ID: 3634296
[TBL] [Abstract][Full Text] [Related]
19. [The pulmonary surfactant system: physiology, pathologies associated with its alteration and exogenous administration as therapeutic and diagnostic agent].
Calmanovici G; Boccio J; Lysionek A; Salgueiro M; Caro R; Hager A; de Paoli T; Zubillaga M
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(4):175-90. PubMed ID: 9914807
[TBL] [Abstract][Full Text] [Related]
20. Overview of surfactant replacement trials.
Suresh GK; Soll RF
J Perinatol; 2005 May; 25 Suppl 2():S40-4. PubMed ID: 15861172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
